Published in Anal Biochem on October 01, 1981
Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest (1989) 5.75
Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1. J Exp Med (1986) 5.17
Cloning and characterization of two cDNAs coding for human von Willebrand factor. Proc Natl Acad Sci U S A (1985) 3.41
Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins. Biochem J (1989) 3.34
Antigen presentation by supported planar membranes containing affinity-purified I-Ad. Proc Natl Acad Sci U S A (1984) 2.80
Cloning of the alpha chain of human platelet glycoprotein Ib: a transmembrane protein with homology to leucine-rich alpha 2-glycoprotein. Proc Natl Acad Sci U S A (1987) 2.70
Erythroid spectrin, brain fodrin, and intestinal brush border proteins (TW-260/240) are related molecules containing a common calmodulin-binding subunit bound to a variant cell type-specific subunit. Proc Natl Acad Sci U S A (1982) 2.63
Isolation of herpes simplex virus regulatory protein ICP4 as a homodimeric complex. J Virol (1985) 2.20
Lysosomal membrane dynamics: structure and interorganellar movement of a major lysosomal membrane glycoprotein. J Cell Biol (1986) 2.18
Complement evasion by Borrelia burgdorferi: serum-resistant strains promote C3b inactivation. Infect Immun (2001) 2.03
A major 125-kd membrane glycoprotein of Saccharomyces cerevisiae is attached to the lipid bilayer through an inositol-containing phospholipid. EMBO J (1988) 1.98
Radioimmunoimaging with longer-lived positron-emitting radionuclides: potentials and challenges. Bioconjug Chem (2009) 1.98
Interactions of thrombospondin with extracellular matrix proteins: selective binding to type V collagen. J Cell Biol (1984) 1.85
An endogenous MDCK lysosomal membrane glycoprotein is targeted basolaterally before delivery to lysosomes. J Cell Biol (1991) 1.81
Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts. J Clin Invest (1991) 1.79
The alpha and beta chains of human platelet glycoprotein Ib are both transmembrane proteins containing a leucine-rich amino acid sequence. Proc Natl Acad Sci U S A (1988) 1.70
Evidence of normal functional levels of activated protein C inhibitor in combined Factor V/VIII deficiency disease. J Clin Invest (1982) 1.60
Purification and characterization of a polypeptide from chick brain that promotes the accumulation of acetylcholine receptors in chick myotubes. J Cell Biol (1986) 1.60
Receptors for oxidized low-density lipoprotein on elicited mouse peritoneal macrophages can recognize both the modified lipid moieties and the modified protein moieties: implications with respect to macrophage recognition of apoptotic cells. Proc Natl Acad Sci U S A (1999) 1.58
Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice. J Clin Invest (2009) 1.56
A macrophage receptor for oxidized low density lipoprotein distinct from the receptor for acetyl low density lipoprotein: partial purification and role in recognition of oxidatively damaged cells. Proc Natl Acad Sci U S A (1995) 1.49
Monoclonal antibodies that recognize transcription unit proteins on newt lampbrush chromosomes. J Cell Biol (1987) 1.46
The pathway and targeting signal for delivery of the integral membrane glycoprotein LEP100 to lysosomes. J Cell Biol (1992) 1.36
Yersinia enterocolitica serum resistance proteins YadA and ail bind the complement regulator C4b-binding protein. PLoS Pathog (2008) 1.36
Different steady state subcellular distributions of the three splice variants of lysosome-associated membrane protein LAMP-2 are determined largely by the COOH-terminal amino acid residue. J Cell Biol (1997) 1.34
Low density lipoprotein rich in oleic acid is protected against oxidative modification: implications for dietary prevention of atherosclerosis. Proc Natl Acad Sci U S A (1990) 1.34
Effects of oleate-rich and linoleate-rich diets on the susceptibility of low density lipoprotein to oxidative modification in mildly hypercholesterolemic subjects. J Clin Invest (1993) 1.29
The yeast Candida albicans binds complement regulators factor H and FHL-1. Infect Immun (2002) 1.28
Prolactin and prolactin receptors are expressed and functioning in human prostate. J Clin Invest (1997) 1.26
Binding of human extracellular superoxide dismutase C to sulphated glycosaminoglycans. Biochem J (1988) 1.26
Identification and characterization of a protein covalently bound to DNA of minute virus of mice. J Virol (1986) 1.26
The hyphal and yeast forms of Candida albicans bind the complement regulator C4b-binding protein. Infect Immun (2004) 1.25
Enhanced responsiveness of endothelium in the growing/motile state to tumor necrosis factor/cachectin. J Exp Med (1989) 1.24
Circulating serum amyloid P component is the precursor of amyloid P component in tissue amyloid deposits. Clin Exp Immunol (1986) 1.23
Purification and characterization of the guinea pig sigma-1 receptor functionally expressed in Escherichia coli. Protein Expr Purif (2006) 1.22
Low immunogenicity of the common lipoamide dehydrogenase subunit (E3) of mammalian pyruvate dehydrogenase and 2-oxoglutarate dehydrogenase multienzyme complexes. Biochem J (1985) 1.20
Relapsing fever spirochetes Borrelia recurrentis and B. duttonii acquire complement regulators C4b-binding protein and factor H. Infect Immun (2006) 1.19
Plasma clearance of human extracellular-superoxide dismutase C in rabbits. J Clin Invest (1988) 1.18
Production of cytopathology in FRhK-4 cells by BS-C-1-passaged hepatitis A virus. Appl Environ Microbiol (1987) 1.16
Isolation of a neural chondroitin sulfate proteoglycan with neurite outgrowth promoting properties. J Cell Biol (1994) 1.15
Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression. Proc Natl Acad Sci U S A (1990) 1.14
Protein phosphorylation in electrically permeabilized islets of Langerhans. Effects of Ca2+, cyclic AMP, a phorbol ester and noradrenaline. Biochem J (1988) 1.14
Heparan sulfate 2-O-sulfotransferase is required for triglyceride-rich lipoprotein clearance. J Biol Chem (2009) 1.13
Pathogenesis of Acanthamoeba keratitis: carbohydrate-mediated host-parasite interactions. Infect Immun (1997) 1.12
On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety. J Exp Med (1995) 1.12
Effect of intratumoral injection on the biodistribution and the therapeutic potential of HPMA copolymer-based drug delivery systems. Neoplasia (2006) 1.11
A re-assessment of the role of protein kinase C in glucose-stimulated insulin secretion. Biochem J (1987) 1.10
Characterization of complement factor H binding to Yersinia enterocolitica serotype O:3. Infect Immun (2008) 1.10
Modulation of antigen processing and presentation by covalently linked complement C3b fragment. Immunology (1995) 1.08
Identification and characterization of specific binding proteins for growth hormone in normal human sera. J Clin Invest (1986) 1.07
Primary structure of glycans isolated from human leucocyte lactotransferrin. Absence of fucose residues questions the proposed mechanism of hyposideraemia. Biochem J (1990) 1.06
Development of B-lineage cells in the bone marrow of scid/scid mice following the introduction of functionally rearranged immunoglobulin transgenes. Proc Natl Acad Sci U S A (1990) 1.06
Evidence from the use of monoclonal antibody probes for structural heterogeneity of the growth hormone receptor. Biochem J (1985) 1.05
A K+ channel in Xenopus nerve fibres selectively blocked by bee and snake toxins: binding and voltage-clamp experiments. J Physiol (1990) 1.04
Compound heterozygosity at the sphingomyelin phosphodiesterase-1 (SMPD1) gene is associated with low HDL cholesterol. Hum Genet (2003) 1.04
Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b. J Clin Invest (1985) 1.01
Interferon-gamma acts directly on rejecting renal allografts to prevent graft necrosis. Am J Pathol (2001) 1.00
Murine epidermal growth factor: heterogeneity on high resolution ion-exchange chromatography. EMBO J (1983) 1.00
The surface conformation of Sindbis virus glycoproteins E1 and E2 at neutral and low pH, as determined by mass spectrometry-based mapping. J Virol (2000) 0.99
Superoxide mediates the toxicity of paraquat for Chinese hamster ovary cells. Proc Natl Acad Sci U S A (1986) 0.99
Biodistribution of charged F(ab')2 photoimmunoconjugates in a xenograft model of ovarian cancer. Br J Cancer (1997) 0.99
Detection of hepatitis A virus and antibody by solid-phase radioimmunoassay and enzyme-linked immunosorbent assay with monoclonal antibodies. J Clin Microbiol (1985) 0.98
Human platelet glycoprotein IX: an adhesive prototype of leucine-rich glycoproteins with flank-center-flank structures. Proc Natl Acad Sci U S A (1989) 0.98
Identification of the growth hormone-releasing peptide binding site in CD36: a photoaffinity cross-linking study. Biochem J (2004) 0.97
Receptor-mediated endocytosis and nuclear transport of human interleukin 1 alpha. Biochem J (1989) 0.96
Radioimmunofocus assay for detection and quantitation of human rotavirus. J Clin Microbiol (1984) 0.96
150-kD von Willebrand factor binding protein extracted from human vascular subendothelium is type VI collagen. J Clin Invest (1991) 0.95
Effect of complement-protein-C3b density on the binding of complement factor H to surface-bound C3b. Biochem J (1991) 0.95
In vivo turnover studies of C-reactive protein and lipoproteins in the rabbit. Clin Exp Immunol (1984) 0.94
The glycoprotein precursor of concanavalin A is converted to an active lectin by deglycosylation. EMBO J (1992) 0.94
Human serum amyloid P component, a circulating lectin with specificity for the cyclic 4,6-pyruvate acetal of galactose. Interactions with various bacteria. Biochem J (1985) 0.94
Interaction of astrochondrin with extracellular matrix components and its involvement in astrocyte process formation and cerebellar granule cell migration. J Cell Biol (1993) 0.92
An A-ELISA to detect hepatitis A virus in estuarine samples. Appl Environ Microbiol (1987) 0.92
Selective elution of immunoadsorbed anti-(human prolactin) immunoglobulins with enhanced immunochemical properties. Biochem J (1982) 0.91
A nerve terminal anchorage protein from electric organ. J Cell Biol (1986) 0.90
Macrophages lacking scavenger receptor A show a decrease in binding and uptake of acetylated low-density lipoprotein and of apoptotic thymocytes, but not of oxidatively damaged red blood cells. Proc Natl Acad Sci U S A (1997) 0.90
Recognition by recombinant autoimmune thyroid disease-derived Fab fragments of a dominant conformational epitope on human thyroid peroxidase. J Clin Invest (1992) 0.90
Preclinical evaluation of multistep targeting of diasialoganglioside GD2 using an IgG-scFv bispecific antibody with high affinity for GD2 and DOTA metal complex. Mol Cancer Ther (2014) 0.89
Endothelial targeting of polymeric nanoparticles stably labeled with the PET imaging radioisotope iodine-124. Biomaterials (2012) 0.89
Interaction of 4-hydroxynonenal-modified low-density lipoproteins with the fibroblast apolipoprotein B/E receptor. Biochem J (1986) 0.89
Atrial natriuretic factor and sodium nitroprusside increase cyclic GMP in cultured rat lung fibroblasts by activating different forms of guanylate cyclase. Biochem J (1987) 0.89
Tenascin-C contains distinct adhesive, anti-adhesive, and neurite outgrowth promoting sites for neurons. J Cell Biol (1996) 0.89
Covalent binding of C3b to tetanus toxin: influence on uptake/internalization of antigen by antigen-specific and non-specific B cells. Immunology (1996) 0.88
Biodistribution of HPMA copolymer-aminohexylgeldanamycin-RGDfK conjugates for prostate cancer drug delivery. Mol Pharm (2009) 0.88
Identification of a rabbit liver cytosolic binding protein for human growth hormone. Biochem J (1984) 0.87
Influence of structural properties and kinetic constraints on Bacillus cereus growth. Appl Environ Microbiol (1998) 0.86
Specific electrochemical iodination of horse heart myoglobin at tyrosine 103 as determined by Fourier transform ion cyclotron resonance mass spectrometry. Arch Biochem Biophys (2008) 0.86
Prolactin stimulates the JAK2 and focal adhesion kinase pathways in human breast carcinoma T47-D cells. Biochem J (1997) 0.85
Development of a non-extracted 'two-site' immunoradiometric assay for corticotropin utilizing extreme amino- and carboxy-terminally directed antibodies. Biochem J (1984) 0.85
Systemic GLIPR1-ΔTM protein as a novel therapeutic approach for prostate cancer. Int J Cancer (2013) 0.84
Radiometal labeling of recombinant proteins by a genetically engineered minimal chelation site: technetium-99m coordination by single-chain Fv antibody fusion proteins through a C-terminal cysteinyl peptide. Proc Natl Acad Sci U S A (1995) 0.83
Evidence for an interleukin 4-inducible immunoglobulin E uptake and transport mechanism in the intestine. J Exp Med (1994) 0.83
Vasopressin stimulation of adrenocorticotropin hormone (ACTH) in humans. In vivo bioassay of corticotropin-releasing factor (CRF) which provides evidence for CRF mediation of the diurnal rhythm of ACTH. J Clin Invest (1988) 0.82
Generation and tumor recognition properties of two human monoclonal antibodies specific to cell surface anionic phospholipids. Invest New Drugs (2015) 0.81
Use of calcium dependence as a means to study the interaction between growth hormones and their binding proteins in rabbit liver. Biochem J (1988) 0.81
Demonstration of elastin gene expression in human skin fibroblast cultures and reduced tropoelastin production by cells from a patient with atrophoderma. J Clin Invest (1985) 0.81
On the structure of rhinovirus 1A. Virology (1971) 4.57
Adrenocorticotrophic and melanocyte-stimulating peptides in the human pituitary. Biochem J (1974) 3.32
Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin. Nature (1982) 2.31
Monoclonal antibodies to three non-glycosylated antigens of herpes simplex virus type 2. J Gen Virol (1982) 2.23
Physical and genetic analysis of cosmids from the vicinity of the cystic fibrosis locus. Nucleic Acids Res (1987) 2.16
Specific interaction between HPV-16 E1-E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network. Nature (1991) 2.09
Isolation of a new DNA marker in linkage disequilibrium with cystic fibrosis, situated between J3.11 (D7S8) and IRP. Am J Hum Genet (1989) 1.97
The human apolipoprotein L gene cluster: identification, classification, and sites of distribution. Genomics (2001) 1.77
Quantitative determination of reducing sugars, oligosaccharides, and glycoproteins with (3H)borohydride. Anal Biochem (1973) 1.72
The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF. Proc Natl Acad Sci U S A (1992) 1.60
Frontotemporal dementia presenting as schizophrenia-like psychosis in young people: clinicopathological series and review of cases. Br J Psychiatry (2009) 1.55
Second to fourth digit ratio (2D:4D), breast cancer risk factors, and breast cancer risk: a prospective cohort study. Br J Cancer (2012) 1.55
Cloning and characterization of the cDNAs for human and rat corticotropin releasing factor-binding proteins. Nature (1991) 1.51
Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia. Nature (2000) 1.49
A reappraisal of human beta MSH. Nature (1974) 1.46
Evidence of ambiguous processing and selective degradation in the noncapsid proteins of rhinovirus 1A. J Virol (1976) 1.43
Properties of a simplified bioassay for adrenocorticotrophic activity using the steroidogenic response of isolated adrenal cells. J Endocrinol (1973) 1.42
The organisation of the multigene family which encodes the major cell surface protein, pMGA, of Mycoplasma gallisepticum. FEBS Lett (1994) 1.41
Pituitary peptide. Nat New Biol (1973) 1.39
Development of a specific extracted radioimmunoassay for methionine enkephalin in human plasma and cerebrospinal fluid. J Endocrinol (1980) 1.31
Development and validation of a radioimmunoassay for peptides related to beta-melanocyte-stimulating hormone in human plasma: the lipotropins. J Clin Endocrinol Metab (1975) 1.30
Coronary artery disease in Asians in Birmingham. Br Heart J (1984) 1.29
Canine granulocytic anaplasmosis: a review. J Vet Intern Med (2009) 1.29
Development and validation of a specific radioimmunoassay for somatostatin in human plasma. Ann Clin Biochem (1979) 1.26
beta-Endorphin in human cerebrospinal fluid. Lancet (1978) 1.26
Complete amino acid analysis of peptides and proteins after hydrolysis by a mixture of sepharose-bound peptidases. Biochem J (1972) 1.24
Picornaviral gene order: comparison of a rhinovirus with a cardiovirus. J Virol (1973) 1.24
Met-enkephalin circulates in human plasma. Nature (1980) 1.23
Purification and amino acid sequence of melanocyte-stimulating hormone from the dogfish Squalus acanthias. Biochem J (1970) 1.23
Acupuncture in heroin addicts; changes in Met-enkephalin and beta-endorphin in blood and cerebrospinal fluid. Lancet (1979) 1.22
Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides. Front Neuroendocrinol (1995) 1.15
Cellular immunity in congestive cardiomyopathy. The normal cellular immune response. Br Heart J (1985) 1.15
Measurement of the dynamics of stimulation and inhibition of steroidogenesis in isolated rat adrenal cells by using column perfusion. Biochem J (1974) 1.14
Interrelations of some pituitary hormones. Nature (1970) 1.13
Fate of corticotrophins in an isolated adrenal-cell bioassay and decrease of peptide breakdown by cell purification. Biochem J (1974) 1.12
Consensus neuropathological diagnosis of common dementia syndromes: testing and standardising the use of multiple diagnostic criteria. Acta Neuropathol (2002) 1.12
The interaction of growth hormone releasing hormone with other hypothalamic hormones on the release of anterior pituitary hormones. Clin Endocrinol (Oxf) (1986) 1.12
Clinicopathologic and diagnostic imaging characteristics of systemic aspergillosis in 30 dogs. J Vet Intern Med (2008) 1.09
Hereditary diffuse leucoencephalopathy with spheroids. J Neurol Neurosurg Psychiatry (2003) 1.08
The effects of dopamine, bromocriptine, lergotrile and metoclopramide on prolactin release from continuously perfused columns of isolated rat pituitary cells. Clin Endocrinol (Oxf) (1979) 1.08
Preparation of growth hormone free from contamination with unconventional slow viruses. Lancet (1985) 1.08
The structure and expression of the preproenkephalin gene. Nucleic Acids Res (1982) 1.06
Influence of maternal and fetal glucokinase mutations in gestational diabetes. Am J Obstet Gynecol (2001) 1.04
Caffeine, performance, and metabolism during repeated Wingate exercise tests. J Appl Physiol (1985) (1998) 1.04
Characterization of a serine protease that cleaves pro-gamma-melanotropin at the adrenal to stimulate growth. Cell (2001) 1.04
Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores. Neurosci Lett (1999) 1.03
Plasma corticotropin-releasing hormone concentrations during pregnancy and parturition. J Clin Endocrinol Metab (1987) 1.03
Chemical characterization of ectopic ACTH purified from a malignant thymic carcinoid tumor. J Clin Endocrinol Metab (1976) 1.02
Decreased growth of human prostate LNCaP tumors in SCID mice fed a low-fat, soy protein diet with isoflavones. Nutr Cancer (1999) 1.02
Human foetal pituitary peptides and parturition. Nature (1976) 1.02
Idiopathic hypothalamic dysfunction: a paraneoplastic syndrome? Lancet (1995) 1.01
Stimulation of adrenal mitogenesis by N-terminal proopiocortin peptides. Nature (1982) 1.01
Confirmation of the 1-20 amino acid sequence of human adrenocorticotrophin. Biochem J (1973) 1.01
A sensitive method for the detection of corticotrophin releasing factor using a perfused pituitary cell column. J Endocrinol (1974) 1.01
mRNA expression profiles for corticotrophin-releasing factor (CRF), urocortin, CRF receptors and CRF-binding protein in peripheral rat tissues. J Mol Endocrinol (2000) 1.00
TDP-43 neuropathology is similar in sporadic amyotrophic lateral sclerosis with or without TDP-43 mutations. Neuropathol Appl Neurobiol (2009) 0.99
The actions of the peptides, neuropeptide Y and peptide YY, on the vascular and capsular smooth muscle of the isolated, blood-perfused spleen of the dog. Br J Pharmacol (1987) 0.99
Perivascular T cells express the pro-inflammatory chemokine RANTES mRNA in multiple sclerosis lesions. Scand J Immunol (1997) 0.98
Control of expression of the I factor, a LINE-like transposable element in Drosophila melanogaster. EMBO J (1996) 0.98
Angioplasty guidewire velocity: a new simple method to calculate absolute coronary blood velocity and flow. Am J Cardiol (1997) 0.97
Isolation of the human plasma corticotrophin-releasing factor-binding protein. J Endocrinol (1989) 0.97
Isolation of human met-enkephalin and two groups of putative precursors (2K-pro-met-enkephalin) from an adrenal medullary tumour. Biochem Biophys Res Commun (1980) 0.96
The pattern and severity of coronary artery disease in Asians and whites living in Birmingham. Postgrad Med J (1983) 0.96
Alpha-1 antitrypsin deficiency: a conformational disease associated with lung and liver manifestations. J Inherit Metab Dis (2008) 0.95
Purification and characterization of a gamma-melanotropin precursor from frozen human pituitary glands. Biochem J (1980) 0.95
Hydrophobic-interaction chromatography and anion-exchange chromatography in the presence of acetonitrile. A two-step purification method for human prolactin. Biochem J (1981) 0.94
Purification and characterization of human neuropeptide Y from adrenal-medullary phaeochromocytoma tissue. Biochem J (1984) 0.94
Large-scale preparation of highly purified pyrogen-free human growth hormone for clinical use. J Endocrinol (1979) 0.94
Corticotropin-releasing factor immunoreactivity in human gastrointestinal tract. Lancet (1982) 0.93
The hydrophobic core sequence modulates the neurotoxic and secondary structure properties of the prion peptide 106-126. J Neurochem (1999) 0.93
Simultaneous release of neurotensin, somatostatin, enkephalins and catecholamines from perfused cat adrenal glands. Neuropeptides (1982) 0.93
Corticotrophin releasing activity in extracts of the stalk median eminence of Brattleboro rats. J Endocrinol (1980) 0.93
Structure and biosynthesis of peptides related to corticotropins and beta-melanotropins. Ann N Y Acad Sci (1977) 0.93
Studies on circulating met-enkephalin and beta-endorphin: normal subjects and patients with renal and adrenal disease. Clin Endocrinol (Oxf) (1981) 0.93
Organic acids in urine from human newborns. Clin Chem (1976) 0.93
Characterization of rat stalk median eminence vasopressin and its involvement in adrenocorticotropin release. Endocrinology (1978) 0.92
Size at birth and adult fat mass in twin sheep are determined in early gestation. J Physiol (2011) 0.92
Amyloidogenicity and neurotoxicity of peptides corresponding to the helical regions of PrP(C). J Neurosci Res (2000) 0.92
Humoral immunity in cardiomyopathy. Br Heart J (1983) 0.92
5-fluorouracil steady state pharmacokinetics and outcome in patients receiving protracted venous infusion for advanced colorectal cancer. Br J Cancer (2001) 0.92
The evolution of vertebrate corticotrophin and melanocyte stimulating hormone. Gen Comp Endocrinol (1975) 0.92
Pharmacokinetics of EMLA cream 5% application to oral mucosa. Anesth Prog (1997) 0.92
Biosynthesis of corticotropin-releasing hormone in human T-lymphocytes. J Neuroimmunol (1993) 0.91
In vitro assay of MSH using skin from the frog Hyla arborea. Gen Comp Endocrinol (1970) 0.91
Selective elution of immunoadsorbed anti-(human prolactin) immunoglobulins with enhanced immunochemical properties. Biochem J (1982) 0.91
Plasma corticotrophin-releasing factor (CRF) in abnormal pregnancy. Br J Obstet Gynaecol (1988) 0.91
Effect of temperature on the radioiodination of human growth hormone. J Immunoassay (1981) 0.91
Corticotropin releasing hormone-binding protein (CRH-BP): plasma levels decrease during the third trimester of normal human pregnancy. J Clin Endocrinol Metab (1993) 0.91
A specific carrier substance for human corticotrophin releasing factor in late gestational maternal plasma which could mask the ACTH-releasing activity. Clin Endocrinol (Oxf) (1988) 0.91
The effect of capsular polysaccharide and lipopolysaccharide of Bacteroides fragilis on polymorph function and serum killing. J Med Microbiol (1984) 0.91
Plasma leptin in female athletes: relationship with body fat, reproductive, nutritional, and endocrine factors. J Appl Physiol (1985) (2000) 0.91
Pro-gamma-melanocyte-stimulating hormone cleavage in adrenal gland undergoing compensatory growth. Nature (1983) 0.90
Local resection of ampullary adenocarcinomas of the duodenum. ANZ J Surg (2001) 0.90